One study found that the loss of NF1, which frequently co-occurs with RAS alterations in melanoma, is associated with loss of negative feedback to RAS activation, resulting in increased activation of RAS and downstream resistance to RAF inhibition [61]. The gene discussed is RAF1; the disease is melanoma.